Prooxidant body system study algorithm with the view of pathogenetic pharmacotherapy option

  • Larisa S. Bakulina M.D., DSci., Full Profes-sor, Dept.of Otorhinolaryngology, Voronezh State Medical University. N.N. Burdenko of the Minis-try of Health of Russia, Voronezh
  • Nikolay N. Pluzhnikov M.D., DSci., Full Pro-fessor, Research Center of Medico-Biological De-fense, St. Petersburg
  • Andrey V. Isaev M.D., Assistant Professor, Dept. of Otorhinolaryngology, Voronezh State Medical University. N.N. Burdenko of the Minis-try of Health of Russia; Associate Professor of Clinical Pharmacology Department at Voronezh State University, Voronezh
Keywords: free radicals, prooxidants, antioxidant system, hydroperoxides, free radical oxidation, spectrophotometric methods, chromatographic methods.

Abstract

Regulatory function of free radical processes in cell vital activity supply/provision and their pres-ence as interim step in a number of vital enzymatic reactions determine the topicality of studies devoted to the assessment of free radicals production and inactivation. The study of prooxidant and antioxidant systems and the free radical oxidation intensity makes it possible to solve a lot of problems such as dynamics detec-tion of pathological process activity, the prognosis of one or another pathological condition, the choice of possible ways of prooxidant and antioxidant balance pharmacological correction in inflammatory diseases as well.

Initiation and maintenance of oxidative stress as well as structure impairment and cell death are sometimes considered associated with cell membrane impairment and their lipids peroxidation. The devel-opment of prooxidant system activity rates study algorithm through up-to-date spectrophotometric and chro-matographic methods makes it possible to define and assess step-by-step the rates obtained.

Downloads

Download data is not yet available.

References

1. Pluzhnikov N.N., CHizh S.M., YUzvinkevich L.S. // Aktual'nye problemy i perspektivy razvitiya voennoj mediciny: nauch. tr. NIIC (MBZ) GNIIIVM MO RF, SPb, 2000, Vol. 2, pp. 193-223.
2. Arutyunyan A.V., Dubinina E.E., Zybina N.N. Metody ocenki svobodnoradikal'nogo okisleniya i antioksidantnoj sistemy organizma, SPb, 2000, 103 p.
3. ZHerebcov N.A., Popova T.N., Artyuhov V.G. Biohimiya: Uchebnik,Voronezh, Izd-vo VGU, 2002, 696 p.
4. N.N. Pluzhnikov [ i dr.], Aktual'nye problemy i perspektivy razvitiya voennoj mediciny: nauch. tr. NIIC (MBZ) GNIIIVM MO R, SPb., 2003, Vol. 4, pp. 123-139.
5. Gennis R. Biomembrany: molekulyarnaya struktura i funkcii: per. s angl., M., Mir, 1997, 624 p.
6. Floyd R.A., Hensley K., Neurobio. Aging., 2002, Vol 23, pp. 795-807.
7. Vladimirov YU.A. Perekisnoe okislenie lipidov v biologicheskih membranah, M., Nauka, 1972, 167 p.
8. Lewis S.E., Wills E.D., Biochem. Pharmacol., 1962, Vol. 11, pp. 901.
9. Cadet J.M., Bellon S., Berger M., J. Biol. Chem., 2002,Vol. 383, No 6, pp. 933-943.
10. Floyd R.A., Anal.Biochem., 1990, Vol 188, pp. 155-158.
11. M. Inoue, Jpn. J. Cancer Res., 1998, Vol. 89, pp. 691-695.
12. Tagesson C., Euгор. J. Cancer, 1995, No 6, pp. 934-940.
13. Hideg E., Plant. Cell. Physiol., 2002, Vol. 43, No 10, pp. 1154-1164.
14. Rost M., Karge E., Klinger W., J. Biolumin. Chemilumin., 1998, Vol. 13, No 6, pp. 355-363.
15. Shen H.M., Yang C.F., Ong C.N., Intern. J. Cancer, 1999, Vol. 81, No 5, pp. 820-828.
16. Faulkner K., Fridovich I., Free Radic. Biol. Med., 1993, Vol 15, No 4, pp. 447-451.
17. Liochev S.I., Fridovich I., Arch. Biochem. Biophys., 1997, Vol. 337, No 1, pp. 115-120.
18. Kratnov A.E., Klin. lab. Diagnostika, 2002, No 6, pp. 6-13.
19. Kurtasova L.M., Klin. lab. Diagnostika, 2003, No 2, pp. 16-18.
20. Waud W.R., Rajagopalan K.V., Arch. Biochem. Biophys., 1976, Vol. 172, No 2, pp. 365-379.
21. But P.G., lzv. Akad. Nauk: Ser. Biol., 2002, No 3, pp. 266-270.
22. Samsonov G.K., Melenevskij A.T., Sorbtsionnye i khromatograficheskie metody fiziko-himicheskoj biotekhologii, L., Nauka, 1986, 229 p.
23. Davankov V.A. Navratil Dzh., Uolton H. Ligandoobmennaya hromatografiya, M., Mir, 1990, 294 p.
24. Selemenev V.F., Kotova D.L., Oros G.YU., Zagorodnij A.A., V kn. «100 let hromatografii», M., Nauka, 2003, pp. 546-569.
25. Selemenev V.F. Dis. … d-ra him. nauk., Voronezh, 1993, 594 p.
26. Temirov YU.P., SHostenko YU.V., SHein A.T., Khim.–farmacevt. Zhurnal, 1978, Vol. 12, No 10, pp. 114-117.
27. Shtykov S.N. Lyuminescentnyj analiz v organizovannyh sredah, V kn. «Lyuminescentnyj analiz», Pod red. G. I. Romanovskoj, 2015, pp. 121-155.
28. Selemenev V.F., Rudakov O.B., Slavinskaya G.I., Drozdova N.V. Pigmenty pischevyh proizvodstv, M., DeLi print, 2008, 246 p.
29. Archakov A.I., Karuzina I.I., Vesti. AMN SSSR, 1988, No 1, pp. 14-23.
30. Bakibaev A.A. et al., Khim.-farmac. zhurn., 1995, No 3, pp. 3-14.
31. Mishin V.M. Mnozhestvennye formy citohroma R-450, Novosibirsk, 1985, 182 p.
32. Saprin A.N., Uspekhi biol. Himii, 1991, Vol. 32, pp. 146-175.
33. Gavrieli Y., Sherman Y., Ben-Sasson S.A., J. Cell. Biol., 1992, Vol. 119, No 3, pp. 493-501.
34. Nicoletti I.A., Migliorati G., Pagliacci M.C., J. Immunol. Meth., 1991, Vol. 139, No 2, pp. 271-279.
Published
2018-10-12
How to Cite
Bakulina, L. S., Pluzhnikov, N. N., & Isaev, A. V. (2018). Prooxidant body system study algorithm with the view of pathogenetic pharmacotherapy option. Sorbtsionnye I Khromatograficheskie Protsessy, 18(5), 766-775. https://doi.org/10.17308/sorpchrom.2018.18/605